Seòmar agus comataidhean

The Scottish Government would expect all employers to ensure that all staff have the necessary rest breaks and support; and this was re-emphasised by the Chief Pharmaceutical Officer in her joint letter with the leaders from the pharmacy sector, including the Royal Pharmaceutical Society, to the service on 8 December outlining the importance of wellbeing to all pharmacy staff and detailing support available.

The COVID-19 pandemic has shown to us all the value which the pharmacy profession bring to the NHS in Scotland be that hospital, community pharmacy or general practice settings. In particular the pharmacy network has been pivotal in the NHS response to the current pandemic in ensuring people across the country have continued access to their medicines and professional healthcare advice. We take the wellbeing of pharmacy teams very seriously and that is why we have made £12m available to support the wellbeing of the pharmacist workforce. That includes £8m from the NHS Recovery Plan to provide ongoing wellbeing support for the workforce – alongside an extra £4m to provide further support to address winter pressures.

The funding supports the 24/7 National Wellbeing Helpline, our National Wellbeing Hub, Coaching for Wellbeing and the Workforce Specialist Service, alongside tailored psychological interventions for staff, providing individualised wellbeing support focusing on people’s physical and emotional needs.

Wider workforce issues and challenges will be discussed at the Chief Pharmaceutical Officer’s Workforce Forum, which will bring together stakeholders from pharmacy education and pharmacy service provision to set a strategic workforce plan for the profession.

I refer to member to the answer to question S6W-05124 on 10 January 2022. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

The Scottish Government has no plans to revise its ambitious woodland creation targets as a result of Storm Arwen. Neither is there any plans to review species of trees to be planted as the range of species already being planted adds to Scotland’s rich, abundant and thriving landscape.

This year the Scottish Government has made £12m available to support the wellbeing of the pharmacist workforce. That includes £8m from the NHS Recovery Plan to provide ongoing wellbeing support for the workforce – alongside an extra £4m to provide further support to address winter pressures.

The funding supports the 24/7 National Wellbeing Helpline, our National Wellbeing Hub, Coaching for Wellbeing and the Workforce Specialist Service, alongside tailored psychological interventions for staff, providing individualised wellbeing support focusing on people’s physical and emotional needs.

The Chief Pharmaceutical Officer for Scotland in a joint letter, issued 8 December, with the leaders from the pharmacy sector, including the Royal Pharmaceutical Society (Scotland), has written to all pharmacy teams outlining the range of wellbeing support available to pharmacy teams and encouraging them to access these resources for support when needed.

This year the Scottish Government has made £12m available to support the wellbeing of the pharmacist workforce. That includes £8m from the NHS Recovery Plan to provide ongoing wellbeing support for the workforce – alongside an extra £4m to provide further support to address winter pressures.

The funding supports the 24/7 National Wellbeing Helpline, our National Wellbeing Hub, Coaching for Wellbeing and the Workforce Specialist Service, alongside tailored psychological interventions for staff, providing individualised wellbeing support focusing on people’s physical and emotional needs.

The Chief Pharmaceutical Officer for Scotland in a joint letter, issued 8 December, with the leaders from the pharmacy sector, including the Royal Pharmaceutical Society (Scotland), has written to all pharmacy teams outlining the range of wellbeing support available to pharmacy teams and encouraging them to access these resources for support when needed.

We engaged with a range of stakeholders to inform the development of the draft Framework for Pain Management Service Delivery including the people with lived experience who were members of the National Advisory Committee for Chronic Pain (NACCP).

The structure and membership of the Committee was reviewed in 2020 in order to increase representation of people with lived experience and other key groups with an interest in improving care and support for people with chronic pain. As set out in the updated Terms of Reference, the Committee is advisory in nature, and members were encouraged to seek consensus in providing advice. The Committee met in its new format in February and May 2021 with all members invited to attend these meetings. Members were also asked to provide feedback and responses a number of other relevant request between meetings.

All members of the Committee had the opportunity to freely share their views on the priorities for improving pain management support which were used to inform the development of the draft Framework. Lived experience members of the Committee were provided with additional support in their role in a number of ways including: meetings to gather the views of a wider cohort of people with chronic pain via the Chronic Pain Patient Reference Group; being offered the choice to participate in capacity building sessions; and being offered the opportunity to directly share a summary of the views of people with chronic pain both in advance with officials and during Committee meetings as part of dedicated agenda items. We have also carried out a Scotland-wide survey to better understand the priorities of people with chronic pain and increase the range of voices involved.

All members of the Committee had access to the same information and resources throughout the development of the Framework, and were provided with a draft version in advance of the launch of the public consultation.

As communicated to the Committee previously, we are currently reviewing existing stakeholder engagement processes and structures, including the NACCP, to ensure that they are fit for purpose and can meaningfully support the future delivery and implementation of the Framework once the current public consultation has been completed.

An aim of the refreshed Out-of-Hospital Strategy 2021 to 2026 is to ensure that 20% of all OHCAs will have a defibrillator applied before the arrival of ambulance service. We want to improve bystander confidence in the use of these devices and the Strategy includes an aim for the Save a Life for Scotland partnership to increase familiarisation with defibrillator usage across Scotland, through embedding defibrillator usage in awareness raising campaigns and CPR training.

The Scottish Government continues to work with NHS National Education for Scotland (NES) and the Royal Pharmaceutical Society in developing a joint programme to encourage more students, and not just school leavers, to consider careers in pharmacy, including ensuring the output reaches deprived and remote and rural communities.

In addition, both Schools of Pharmacy work towards the widening access targets set by the Commission on Widening Access for universities to drive forward the delivery of equal access in Scotland.

There are also wider initiatives such as The Scottish Wider Access Programme (SWAP). The partnership develops access programmes for adults returning to education, and targets adults who reside in the most disadvantaged areas of Scotland and particularly those who have no, few or out of date qualifications. This can help support people with few suitable qualifications to progress to degree level Pharmacy studies.

There are approximately 240 students each year who graduate from the two Schools of Pharmacy in Scotland. There has been an increase in the overall numbers of students studying pharmacy with more Scottish domiciled students undertaking the course. The two Schools of Pharmacy in Scotland are encouraging applicants from parts of Scotland where there are gaps in the pharmacy workforce and working with schools to promote pharmacy as a career.

Since 2018, the number of NHS pre-registration pharmacists places funded nationally has increased from 170 in 2018 up to 231 in 2020-21. In 2021-22, funding of £6,096,489 was provided to NHS Education in Scotland (NES) for the Pre-registration Pharmacy Scheme, for 231 places. By 2024-25 this will have increased by a further 89 places to bring the total to an additional 120 pharmacist trainees over 5 years staying in Scotland to complete their pre-registration training.

In order to meet future workforce demands, a five year integrated initial education programme for pharmacists in Scotland has been developed. The first students to graduate from the new programme will qualify in 2027 with co-terminus graduation and registration. This will better prepare newly qualified pharmacists for practice, strengthen the clinical workforce, particularly in primary care, and manage trainee numbers to meet workforce requirements.

The Scottish Government is committed to having a pharmacist independent prescriber in every community pharmacy. As of December 2020 there were a total of 1585 pharmacists qualified prescribers or currently undertaking an independent prescribing qualification. As demand for pharmacy technicians grow and a skill mix is increasingly required in different pharmacy settings, increasing the pipeline of pharmacy technicians has become a priority. We are currently working with key stakeholders to develop a national pharmacy technician apprenticeship scheme.

As part of the overall 2021-22 community pharmacy financial package, a total of £2.751m provides each community pharmacy contractor with a monthly contribution of £180 towards staff training beyond pharmacists and pharmacy technicians.

We welcomed the launch of the Circuit, which aims to improve access to defibrillators across the UK. We would urge all defibrillator guardians to register their defibrillator so that the Scottish Ambulance Service call handlers can direct people to them in incidents of cardiac arrest. Registration of defibrillators in Scotland will build the evidence to support people and organisations in making informed decisions about where to place their life saving device.